Day: June 22, 2020

LAKE FOREST, Ill., June 22, 2020 (GLOBE NEWSWIRE) — Akorn, Inc. (OTC Pink Market: AKRXQ), a leading specialty generic pharmaceutical company, today announced the launch of its Abbreviated New Animal Drug Application (ANADA) for Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment, USP (BNP). The product is manufactured at Akorn’s Somerset, New Jersey manufacturing site.Douglas Boothe, Akorn’s President and Chief Executive Officer, stated, “This is an important launch for veterinarians and Akorn as there has been a shortage in the market for veterinary approved ophthalmics. We are pleased that our distributor partners will have BNP commercially available in both distributor and Akorn labels.”Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment, USP is indicated for the treatment of superficial...

Transformative acquisition of IXINITY® completed February 28, 2020Fiscal 2020 Metoject® unit market demand increased 96%;Rupall™ unit market demand increased 61%; andRasuvo® unit market demand increased 11%Medexus management to host conference call at 8:00 AM ET on Tuesday, June 23, 2020MONTREAL, June 22, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today provided a business update and announced its financial and operating results for the fourth quarter and fiscal year ended March 31, 2020.  All dollar amounts contained in this press release are in Canadian dollars unless otherwise indicated.Fourth quarter fiscal 2020 financial highlights**:Revenue increased to $25.6 million compared to $12.7 million for Q4 2019, including organic growth of 27%Gross profit increased...

Paris, Amsterdam, June 22, 2020Press releaseUnibail-Rodamco-Westfield (“URW”) announces the successful placement of €750 Mn of bondsURW today successfully priced a €750 Mn senior bond offering with a 12-year maturity and a 2.0% fixed coupon.The offering attracted strong demand with the order book exceeding €1.6 Bn.The net proceeds from this issuance will be used for general corporate purposes, including the refinancing of debt maturing in 2020 and extending the Group’s debt maturity.The Group will have €12.7 Bn in cash on hand and undrawn credit lines upon closing of the senior bond offering.For further information, please contact:Investor Relations Samuel WarwoodMaarten Otte +33 1 76 77 58 02 Maarten.otte@urw.comMedia Relations Tiphaine Bannelier-Sudérie+33 1 76 77 57 94Tiphaine.Bannelier-Suderie@urw.comAbout Unibail-Rodamco-WestfieldUnibail-Rodamco-Westfield...

LOUISVILLE, Ky., June 22, 2020 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) announced today that Arlington International Racecourse (“Arlington”) in Arlington Heights, Illinois reached an agreement with the Illinois Thoroughbred Horsemen’s Association (“ITHA”) for the 2020 and 2021 live race meets. The Illinois Racing Board (“IRB”) unanimously approved Arlington’s 2020 Summer Meet permitting live racing without spectators from July 23 to September 26, 2020. “We are pleased to welcome back the trainers and owners of Illinois who have expressed their desire to race at Arlington,” said Tony Petrillo, President of Arlington. “This approval will allow us to bring back the thousands of jobs that rely on racing at Arlington.”Arlington’s backstretch will open to owners and trainers on or before July 6. The 2020...

BOULDER, Colo., June 22, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced preclinical safety and efficacy data for MRG-229, a next-generation miR-29 mimic intended for systemic administration and targeted delivery, in Idiopathic Pulmonary Fibrosis‎ (IPF).“MRG-229 has demonstrated mechanistic biomarker regulation and antifibrotic activity in vitro using human model systems. In addition, subcutaneous administration of the product candidate induced the reversal of pathologic fibrotic gene expression and resulted in a significant reduction of fibrosis in the most commonly employed pre-clinical animal model of pulmonary fibrosis. Finally, high doses of MRG-229 in preclinical toxicology studies...

Gaithersburg, MD, June 22, 2020 (GLOBE NEWSWIRE) — Verus International, Inc. (“Verus” or the “Company”) (OTCQB: VRUS) reported record results for its second fiscal quarter ended April 30, 2020. In conjunction with this release, the Company is also providing additional details on its business outlook for the second half of fiscal year 2020.For fiscal Q2 2020, management is noting the following items of importance:Revenue set an all-time 2nd quarter record, reaching $4.6 million, an increase of 58% over the $2.9 million reported in Q2 2019.Due to pandemic-related port and store closures, a portion of expected Q2 2020 revenue shifted into Q3 2020.Gross profit margin improved to 15.8%, 46 basis points higher than the 15.4% reported in Q2 2019.Operating expenses of $7.7 million were $7.0 million higher than the $0.7 million reported in...

HOUSTON, June 22, 2020 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced Michael Raleigh, CEO will participate in the virtual East Coast IDEAS Investor Conference on June 24, 2020. EPSN’s presentation is scheduled to be available at 8:00 am CST on June 24th on the company’s website: http://www.EPSILONENERGYLTD.com.  The presentation will also be webcasted and can be accessed through the conference website, www.IDEASconferences.com.About Epsilon

WINNEMUCCA, Nev., June 22, 2020 (GLOBE NEWSWIRE) — Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announced today that it has commenced a non-brokered registered direct offering (“RD”) of shares to certain US based and other eligible investors. Concurrent to the RD, the Company has engaged Canaccord Genuity Corp. and Cantor Fitzgerald Canada Corporation as agents for a Canadian best efforts offering for minimum aggregate gross proceeds of US$3 million (the “Offerings”).  Closing of the Offerings is anticipated to occur on or about June 30, 2020, subject to the satisfaction of customary closing conditions, including approval of the NYSE American stock exchange.Proceeds from the Offerings will be used primarily to advance the ongoing permitting of the Company’s high-grade Grassy Mountain gold project...

CHICAGO, June 22, 2020 (GLOBE NEWSWIRE) — Royal Financial, Inc. (the “Company”) (OTCQX: RYFL), incorporated under the laws of Delaware on March 15, 2004, for the purpose of serving as the holding company of Royal Savings Bank (the “Bank”), announced a loss for the third quarter of fiscal year 2020.The Company reported net loss of ($578,000), or ($0.23) per common share, for the quarter and $1.0 million or $0.39 per common share, for the nine-month year-to-date (“YTD”) period, respectively, ended March 31, 2020. The Company also reported total assets of $394.9 million and stockholders’ equity of $41.8 million as of March 31, 2020.  As of the same date, the Company’s book value per share was $16.35 and tangible book value per share was $15.39.The COVID-19 Pandemic Creates Significant Risks and Uncertainties for Our Business.The World...

DERIDDER, La., June 22, 2020 (GLOBE NEWSWIRE) — AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers’ compensation insurance focused on high hazard industries, today announced it will release its 2020 second quarter financial results on Thursday, July 30, 2020 after the market closes. In conjunction with the release, the Company has scheduled a conference call which will be broadcast live over the Internet on Friday, July 31, 2020 at 10:30AM Eastern time.An archive of the webcast will be available after the call for a period of 60 days in the “Investors” section of the Company’s website.About AMERISAFEAMERISAFE, Inc. is a specialty provider of workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, and...